Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts. [electronic resource]
Producer: 20011227Description: 16-20 p. digitalISSN:- 0022-4804
- Animals
- Carcinoma -- genetics
- Colonic Neoplasms -- genetics
- Cytoskeletal Proteins -- antagonists & inhibitors
- Dose-Response Relationship, Drug
- Down-Regulation
- Female
- Genes, APC
- Humans
- Mice
- Mice, Inbred BALB C
- Mutation
- Neoplasm Transplantation
- Oligonucleotides, Antisense -- pharmacology
- Trans-Activators
- Transplantation, Heterologous
- Tumor Cells, Cultured -- transplantation
- beta Catenin
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.